Cargando…

Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis

BACKGROUNDS: Pulmonary tuberculosis (PTB) is a major health and economic burden. Accurate PTB detection is an important step to eliminating TB globally. Interferon gamma-induced protein 10 (IP-10) has been reported as a potential diagnostic marker for PTB since 2007. In this study, a meta-analysis a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Xia, Xiong, Tao, Su, Xiaojuan, Qu, Yi, Ge, Long, Yue, Yan, Zeng, Yan, Li, Wenxing, Hu, Peng, Mu, Dezhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822474/ https://www.ncbi.nlm.nih.gov/pubmed/31666025 http://dx.doi.org/10.1186/s12879-019-4466-5

Ejemplares similares

Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: A meta-analysis
por: Qiu, Xia, et al.
Publicado: (2019)

Prognostic values of serum IP-10 and IL-17 in Patients with Pulmonary Tuberculosis
por: Chen, Yung-Che, et al.
Publicado: (2011)

Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10
por: Zhang, Yao, et al.
Publicado: (2014)

Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis
por: Kim, Song Yee, et al.
Publicado: (2018)

Plasma levels of CRP, neopterin and IP-10 in HIV-infected individuals with and without pulmonary tuberculosis
por: Ciccacci, Fausto, et al.
Publicado: (2019)

Diagnostic performance of adenosine deaminase for abdominal tuberculosis: A systematic review and meta-analysis
por: Zhou, Ruixi, et al.
Publicado: (2022)

The Regulatory Network of METTL3 in the Nervous System: Diagnostic Biomarkers and Therapeutic Targets
por: Su, Xiaojuan, et al.
Publicado: (2023)

Elevated IP-10 at the Protein and Gene Level Associates With Pulmonary TB
por: Fisher, Kimone L., et al.
Publicado: (2022)

Use of anti-tuberculosis drugs among newly diagnosed pulmonary tuberculosis inpatients in China: a retrospective study
por: Huang, Fei, et al.
Publicado: (2016)

Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper
por: Aabye, Martine G., et al.
Publicado: (2013)

IP-10 for the diagnosis of tuberculosis in children: Protocol for a systematic review and meta-analysis
por: Zhang, Weijun
Publicado: (2019)

IP-10 Is a Potential Biomarker of Cystic Fibrosis Acute Pulmonary Exacerbations
por: Solomon, George M., et al.
Publicado: (2013)

Direct Gene Transfer with IP-10 Mutant Ameliorates Mouse CVB3-Induced Myocarditis by Blunting Th1 Immune Responses
por: Yue, Yan, et al.
Publicado: (2011)

The Roles of High Mobility Group Box 1 in Cerebral Ischemic Injury
por: Gou, Xiaoyun, et al.
Publicado: (2020)

Limitations of Chest Radiography in Diagnosing Subclinical Pulmonary Tuberculosis in Canada
por: Long, Richard, et al.
Publicado: (2023)

Blood or Urine IP-10 Cannot Discriminate between Active Tuberculosis and Respiratory Diseases Different from Tuberculosis in Children
por: Petrone, Linda, et al.
Publicado: (2015)

Is IP-10 a Better Biomarker for Active and Latent Tuberculosis in Children than IFNγ?
por: Whittaker, Elizabeth, et al.
Publicado: (2008)

Is IP-10 an Accurate Marker for Detecting M. tuberculosis-Specific Response in HIV-Infected Persons?
por: Goletti, Delia, et al.
Publicado: (2010)

Elevated OPN, IP-10, and Neutrophilia in Loop-Mediated Isothermal Amplification Confirmed Tuberculosis Patients
por: Shiratori, Beata, et al.
Publicado: (2014)

IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2015)

Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions
por: Blauenfeldt, Thomas, et al.
Publicado: (2018)

Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis
por: Tang, Nelson Leung-Sang, et al.
Publicado: (2009)

Delayed Treatment of Diagnosed Pulmonary Tuberculosis in Taiwan
por: Chern, Jimmy PS, et al.
Publicado: (2008)

Diagnosing sputum/smear negative pulmonary tuberculosis
por: Vengattaraman, Sivaraman
Publicado: (2010)

Urine PCR Evaluation to Diagnose Pulmonary Tuberculosis
por: Heydari, Ali Akbar, et al.
Publicado: (2014)

Acceptability of Sputum Specimens for Diagnosing Pulmonary Tuberculosis
por: Lee, Yeon Joo, et al.
Publicado: (2015)

Diagnosing pulmonary tuberculosis by pooling induced sputum
por: Chew, Mei Ying, et al.
Publicado: (2019)

Clinical characteristics of severe neonatal enterovirus infection: a systematic review
por: Zhang, Meng, et al.
Publicado: (2021)

Evaluation of the Diagnostic Potential of IP-10 and IL-2 as Biomarkers for the Diagnosis of Active and Latent Tuberculosis in a BCG-Vaccinated Population
por: Wang, Sen, et al.
Publicado: (2012)

Sustained signalling by PTH modulates IP(3) accumulation and IP(3) receptors through cyclic AMP junctions
por: Meena, Abha, et al.
Publicado: (2015)

Plasma interferon-γ-inducible protein 10 (IP-10) levels correlate with disease severity and paradoxical reactions in extrapulmonary tuberculosis
por: Suárez, Isabelle, et al.
Publicado: (2020)

IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy
por: Kabeer, Basirudeen Syed Ahamed, et al.
Publicado: (2011)

Added Value of IP-10 as a Read-Out of Mycobacterium tuberculosis: Specific Immunity in Young Children
por: Jenum, Synne, et al.
Publicado: (2016)

Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-γ, IP-10 and adenosine deaminase
por: Santos, Ana Paula, et al.
Publicado: (2018)

Kinetics of Granuloma, IFN-γ and IP-10 in a Wistar Rat Model Infected with Mycobacterium Tuberculosis
por: Singh, Bobby, et al.
Publicado: (2022)

An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis
por: Yates-Binder, Cecelia C., et al.
Publicado: (2012)

Research Progress on the Role and Mechanism of Action of Activin A in Brain Injury
por: Su, Xiaojuan, et al.
Publicado: (2018)

Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?
por: Xiao, Dongqiong, et al.
Publicado: (2021)

Pericytes in Cerebrovascular Diseases: An Emerging Therapeutic Target
por: Su, Xiaojuan, et al.
Publicado: (2019)

Research Progress on the Cardiac Injury from ACE2 Targeting in SARS-CoV-2 Infection
por: Sun, Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2qjljpm7so2f9ih2eh2ev3au98